BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20347606)

  • 1. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.
    Kalla Singh S; Tan QW; Brito C; De León M; De León D
    Growth Horm IGF Res; 2010 Jun; 20(3):245-54. PubMed ID: 20347606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
    Kalla Singh S; Tan QW; Brito C; De León M; Garberoglio C; De León D
    Growth Horm IGF Res; 2010 Apr; 20(2):162-70. PubMed ID: 20089431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.
    Schnarr B; Strunz K; Ohsam J; Benner A; Wacker J; Mayer D
    Int J Cancer; 2000 Nov; 89(6):506-13. PubMed ID: 11102895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.
    Grunda JM; Steg AD; He Q; Steciuk MR; Byan-Parker S; Johnson MR; Grizzle WE
    BMC Res Notes; 2012 May; 5():248. PubMed ID: 22616718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
    Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factors in human breast cancer.
    Ellis MJ; Jenkins S; Hanfelt J; Redington ME; Taylor M; Leek R; Siddle K; Harris A
    Breast Cancer Res Treat; 1998; 52(1-3):175-84. PubMed ID: 10066081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.
    Govindarajan R; Posey J; Chao CY; Lu R; Jadhav T; Javed AY; Javed A; Mahmoud FA; Osarogiagbon RU; Manne U
    BMC Cancer; 2016 Jun; 16():368. PubMed ID: 27316467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
    Vallega KA; Liu N; Myers JS; Yu K; Sang QX
    PLoS One; 2016; 11(6):e0157741. PubMed ID: 27314854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
    Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
    Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.
    Zaanan A; Calmel C; Henriques J; Svrcek M; Blons H; Desbois-Mouthon C; Merabtene F; Goumard C; Parc Y; Gayet B; Taieb J; Validire P; Louvet C; Fléjou JF; Le Bouc Y; Praz F
    Cell Oncol (Dordr); 2020 Apr; 43(2):237-247. PubMed ID: 31823290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
    Chong KY; Subramanian A; Mokbel K; Sharma AK
    J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
    Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
    BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds.
    Ludwig T; Eggenschwiler J; Fisher P; D'Ercole AJ; Davenport ML; Efstratiadis A
    Dev Biol; 1996 Aug; 177(2):517-35. PubMed ID: 8806828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
    Stewart PA; Luks J; Roycik MD; Sang QX; Zhang J
    PLoS One; 2013; 8(12):e82460. PubMed ID: 24324792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
    Tian D; Mitchell I; Kreeger PK
    BMC Syst Biol; 2016 Feb; 10():15. PubMed ID: 26861122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
    Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
    Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites.
    Hoyo C; Murphy SK; Schildkraut JM; Vidal AC; Skaar D; Millikan RC; Galanko J; Sandler RS; Jirtle R; Keku T
    Dis Markers; 2012; 32(2):133-41. PubMed ID: 22377707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.
    Deshmukh SK; Srivastava SK; Bhardwaj A; Singh AP; Tyagi N; Marimuthu S; Dyess DL; Dal Zotto V; Carter JE; Singh S
    Oncotarget; 2015 May; 6(13):11231-41. PubMed ID: 25868978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race-associated biological differences among Luminal A breast tumors.
    D'Arcy M; Fleming J; Robinson WR; Kirk EL; Perou CM; Troester MA
    Breast Cancer Res Treat; 2015 Jul; 152(2):437-48. PubMed ID: 26109344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.